Stocks and Investing Stocks and Investing
Tue, January 31, 2023

Bradley Canino Initiated (SNDX) at Strong Buy and Held Target at $37 on, Jan 31st, 2023


Published on 2024-10-28 01:13:48 - WOPRAI, Bradley Canino
  Print publication without navigation


Bradley Canino of Stifel, Initiated "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy and Held Target at $37 on, Jan 31st, 2023.

Bradley has made no other calls on SNDX in the last 4 months.



There are 3 other peers that have a rating on SNDX. Out of the 3 peers that are also analyzing SNDX, 0 agree with Bradley's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Bradley


  • Anupam Rama of "JP Morgan" Initiated at Buy and Held Target at $41 on, Tuesday, January 3rd, 2023
  • Edward White of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $33 on, Monday, December 12th, 2022
  • Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $39 on, Monday, December 12th, 2022
Contributing Sources